Drugs / mesenchymal stromal cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05975892 | Aug 2018 → Aug 2022 | periodontitis, aggressive | Venezuelan Institute for Scientific Research | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mesenchymal stromal cells | “allogeneic bone marrow mesenchymal stromal cells (MSC) to induce bone regeneration” NCT05975892 ↗ |
| Known as | MSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05975892 ↗ |
| Modality | Cell therapy | “Transplantation of allogeneic MSCs in periodontal disease” NCT05975892 ↗ |
| Route | Other | “implanted in the bone defect” NCT05975892 ↗ |